294 related articles for article (PubMed ID: 9833858)
1. Treatment of early AIDS-related Kaposi's sarcoma with oral all-trans-retinoic acid: results of a sequential non-randomized phase II trial. Kaposi's Sarcoma ANRS Study Group. Agence Nationale de Recherches sur le SIDA.
Saiag P; Pavlovic M; Clerici T; Feauveau V; Nicolas JC; Emile D; Chastang C
AIDS; 1998 Nov; 12(16):2169-76. PubMed ID: 9833858
[TBL] [Abstract][Full Text] [Related]
2. All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study.
Gill PS; Espina BM; Moudgil T; Kidane S; Esplin JA; Tulpule A; Levine AM
Leukemia; 1994; 8 Suppl 3():S26-32. PubMed ID: 7808021
[TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of oral 9-cis-retinoic acid in HIV-associated Kaposi's sarcoma.
Miles SA; Dezube BJ; Lee JY; Krown SE; Fletcher MA; Saville MW; Kaplan L; Groopman J; Scadden DT; Cooley T; Von Roenn J; Friedman-Kien A;
AIDS; 2002 Feb; 16(3):421-9. PubMed ID: 11834954
[TBL] [Abstract][Full Text] [Related]
4. Virologic and immunologic parameters that predict clinical response of AIDS-associated Kaposi's sarcoma to highly active antiretroviral therapy.
Pellet C; Chevret S; Blum L; Gauvillé C; Hurault M; Blanchard G; Agbalika F; Lascoux C; Ponscarme D; Morel P; Calvo F; Lebbé C
J Invest Dermatol; 2001 Oct; 117(4):858-63. PubMed ID: 11676823
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II study of intermittent all-trans-retinoic acid, alone and in combination with interferon alfa-2a, in patients with epidemic Kaposi's sarcoma.
Bailey J; Pluda JM; Foli A; Saville MW; Bauza S; Adamson PC; Murphy RF; Cohen RB; Broder S; Yarchoan R
J Clin Oncol; 1995 Aug; 13(8):1966-74. PubMed ID: 7636537
[TBL] [Abstract][Full Text] [Related]
6. The effect of HAART in 254 consecutive patients with AIDS-related Kaposi's sarcoma.
Bower M; Weir J; Francis N; Newsom-Davis T; Powles S; Crook T; Boffito M; Gazzard B; Nelson M
AIDS; 2009 Aug; 23(13):1701-6. PubMed ID: 19550283
[TBL] [Abstract][Full Text] [Related]
7. A multicenter phase II study of the intravenous administration of liposomal tretinoin in patients with acquired immunodeficiency syndrome-associated Kaposi's sarcoma.
Bernstein ZP; Chanan-Khan A; Miller KC; Northfelt DW; Lopez-Berestein G; Gill PS
Cancer; 2002 Dec; 95(12):2555-61. PubMed ID: 12467070
[TBL] [Abstract][Full Text] [Related]
8. A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma.
Nasti G; Errante D; Santarossa S; Vaccher E; Tirelli U
Drug Saf; 1999 May; 20(5):403-25. PubMed ID: 10348092
[TBL] [Abstract][Full Text] [Related]
9. Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma.
Gill PS; McLaughlin T; Espina BM; Tulpule A; Louie S; Lunardi-Iskandar Y; Gallo RC
J Natl Cancer Inst; 1997 Dec; 89(23):1797-802. PubMed ID: 9392621
[TBL] [Abstract][Full Text] [Related]
10. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma.
Lebbé C; Blum L; Pellet C; Blanchard G; Vérola O; Morel P; Danne O; Calvo F
AIDS; 1998 May; 12(7):F45-9. PubMed ID: 9619797
[TBL] [Abstract][Full Text] [Related]
11. Continuous infusion bleomycin in AIDS-related Kaposi's sarcoma.
Remick SC; Reddy M; Herman D; Grace C; Harper G; Willis K; Candon B; Horton J; Ruckdeschel JC
J Clin Oncol; 1994 Jun; 12(6):1130-6. PubMed ID: 7515412
[TBL] [Abstract][Full Text] [Related]
12. Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy.
Schwartsmann G; Sprinz E; Kromfield M; Kalakun L; Sander E; Prolla G; Di Leone L; Gerhardt L; Mans DR
J Clin Oncol; 1997 May; 15(5):2118-24. PubMed ID: 9164226
[TBL] [Abstract][Full Text] [Related]
13. Intralesional bevacizumab in patients with human immunodeficiency virus-associated Kaposi's sarcoma in the upper airway.
Ablanedo-Terrazas Y; Alvarado-de la Barrera C; Ormsby CE; Ruiz-Cruz M; Reyes-Terán G
Laryngoscope; 2015 Apr; 125(4):E132-7. PubMed ID: 25345840
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of recombinant human interferon-alpha 2a and zidovudine in patients with AIDS-related Kaposi's sarcoma. AIDS Clinical Trials Group.
Fischl MA; Finkelstein DM; He W; Powderly WG; Triozzi PL; Steigbigel RT
J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Apr; 11(4):379-84. PubMed ID: 8601224
[TBL] [Abstract][Full Text] [Related]
15. Changing patterns of Kaposi's sarcoma in Danish acquired immunodeficiency syndrome patients with complete follow-up. The Danish Study Group for HIV Infection (DASHI).
Lundgren JD; Melbye M; Pedersen C; Rosenberg PS; Gerstoft J
Am J Epidemiol; 1995 Apr; 141(7):652-8. PubMed ID: 7702040
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of liposomal encapsulated daunorubicin in the treatment of AIDS-associated mucocutaneous Kaposi's sarcoma.
Girard PM; Bouchaud O; Goetschel A; Mukwaya G; Eestermans G; Ross M; Rozenbaum W; Saimot AG
AIDS; 1996 Jun; 10(7):753-7. PubMed ID: 8805866
[TBL] [Abstract][Full Text] [Related]
17. The effects of preparations of human chorionic gonadotropin on AIDS-related Kaposi's sarcoma.
Gill PS; Lunardi-Ishkandar Y; Louie S; Tulpule A; Zheng T; Espina BM; Besnier JM; Hermans P; Levine AM; Bryant JL; Gallo RC
N Engl J Med; 1996 Oct; 335(17):1261-9. PubMed ID: 8857005
[TBL] [Abstract][Full Text] [Related]
18. Administration of pentosan polysulfate to patients with human immunodeficiency virus-associated Kaposi's sarcoma.
Pluda JM; Shay LE; Foli A; Tannenbaum S; Cohen PJ; Goldspiel BR; Adamo D; Cooper MR; Broder S; Yarchoan R
J Natl Cancer Inst; 1993 Oct; 85(19):1585-92. PubMed ID: 7692072
[TBL] [Abstract][Full Text] [Related]
19. Liposomal daunorubicin in advanced Kaposi's sarcoma: a phase II study.
Money-Kyrle JF; Bates F; Ready J; Gazzard BG; Phillips RH; Boag FC
Clin Oncol (R Coll Radiol); 1993; 5(6):367-71. PubMed ID: 8305357
[TBL] [Abstract][Full Text] [Related]
20. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
